Korea's Health Ministry To Unveil Steeper Price Cuts After Patent Loss; Generics Could Be The Big Loser
This article was originally published in The Pink Sheet Daily
Executive Summary
Price cuts that level the cost between generics and off-patent originals would deal another heavy blow to the local pharma industry, which relies primarily on generic sales.